Drug Trial Radar · NCT05698329
Effect of AIV007 by Periocular Administration in Subjects With Macular Edema Secondary to nAMD and DME
Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
19
Actual
Start
Mar 2, 2023
Primary completion
Mar 3, 2025
Study completion Mar 3, 2025
Sponsor
- Lead sponsor
- AiViva BioPharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 26, 2023
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 21 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine safety, pharmacokinetics, and duration of effect of periocularly administered AIV007 gel suspension in subjects with neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME).
Conditions
- Neovascular Age-related Macular Degeneration
- Diabetic Macular Edema
- Macular Edema
Interventions
AIV007Drug
Periocular injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adverse EventsTime frame: Approximately 168 days
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Retina-Vitreous Associates
Beverly Hills, California
Orange County Retina
Santa Ana, California
Verum Research
Eugene, Oregon
Valley Retina Institute
McAllen, Texas
Texas Retina Associates
Plano, Texas
Medical Center Ophthalmology
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.